J. Hirsh and R. Raschke, Heparin and Low-Molecular-Weight Heparin, Chest, vol.126, issue.3, pp.188-203, 2004.
DOI : 10.1378/chest.126.3_suppl.188S

P. Sié, Prise en charge des surdosages en antivitamines K. A propos d'une enquête observationnelle auprès de 70 établissements hospitaliers français, Urgence Pratique, vol.54, pp.3-5, 2002.

D. Wysowski, P. Nourjah, and L. Swartz, Bleeding Complications With Warfarin Use, Archives of Internal Medicine, vol.167, issue.13, pp.1414-1423, 2007.
DOI : 10.1001/archinte.167.13.1414

URL : http://archinte.jamanetwork.com/data/journals/intemed/5601/ioi70070_1414_1419.pdf

B. Boneu, J. Cambus, and F. Guerrero, Les surdosages en antivitamine K, Sang Thrombose Vaisseaux, vol.17, issue.3, pp.175-183, 2005.

L. Linkins, P. Choi, and J. Douketis, Clinical Impact of Bleeding in Patients Taking Oral Anticoagulant Therapy for Venous Thromboembolism, Annals of Internal Medicine, vol.139, issue.11, 2003.
DOI : 10.7326/0003-4819-139-11-200312020-00007

. Haematology, Guidelines on oral anticoagulation (warfarin): third edition -2005 update, Br J Haematology, vol.32, pp.277-85, 2006.

R. Baker, P. Coughlin, and A. Gallus, Warfarin Reversal. Consensus Group Warfarin Reversal: consensus guidelines, on behalf of the Australasian Society of Thromb Haemostat, Med J Aust, vol.181, pp.492-499, 2004.

J. Ansell, J. Hirsh, L. Poller, H. Bussey, A. Jacobson et al., The Pharmacology and Management of the Vitamin K Antagonists, Chest, vol.126, issue.3, pp.204-233, 2004.
DOI : 10.1378/chest.126.3_suppl.204S

B. Vigué, C. Ract, B. Tremey, N. Engrand, P. Leblanc et al., Ultra-rapid management of oral anticoagulant therapy-related surgical intracranial hemorrhage, Intensive Care Medicine, vol.12, issue.4, pp.721-725, 2007.
DOI : 10.1161/01.STR.23.7.972

M. Yasaka, T. Sakata, K. Minematsu, and H. Naritomi, Correction of INR by prothrombin complex concentrate and vitamin K in patients with warfarin related hemorrhagic complication, Thrombosis Research, vol.108, issue.1, pp.25-30, 2002.
DOI : 10.1016/S0049-3848(02)00402-4

K. Fredriksson, B. Norrving, and L. Stromblad, Emergency reversal of anticoagulation after intracerebral hemorrhage, Stroke, vol.23, issue.7, pp.972-979, 1992.
DOI : 10.1161/01.STR.23.7.972

M. Cartmill, G. Dolan, J. Byrne, and P. Byrne, Prothrombin complex concentrate for oral anticoagulant reversal in neurosurgical emergencies, British Journal of Neurosurgery, vol.14, issue.5, pp.458-61, 2000.
DOI : 10.1080/02688690050175265

D. Breuil, A. Umland, and E. , Outpatient management of anticoagulation therapy, Am fam Physician, vol.75, pp.1031-1073, 2007.

A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion et al., Guidelines on the management of valvular heart disease: reply, European Heart Journal, vol.28, issue.10, pp.1-50, 2007.
DOI : 10.1093/eurheartj/ehm095

E. Wijdicks, W. Schievink, R. Brown, and C. Mullany, The Dilemma of Discontinuation of Anticoagulation Therapy for Patients with Intracranial Hemorrhage and Mechanical Heart Valves, Neurosurgery, vol.335, issue.4, pp.769-73, 1998.
DOI : 10.1056/NEJM199608083350607

A. Butler and R. Tait, Restarting anticoagulation in prosthetic heart valve patients after intracranial haemorrhage: a 2-year follow-up, British Journal of Haematology, vol.22, issue.4, pp.1064-1070, 1998.
DOI : 10.1001/archinte.156.11.1197

V. Babikian, C. Kase, M. Pessin, L. Caplan, and P. Gorelick, Resumption of anticoagulation after intracranial bleeding in patients with prosthetic heart valves, Stroke. Mars, vol.19, pp.407-415, 1988.

M. Eckman, J. Rosand, K. Knudsen, D. Singer, and S. Greenberg, Can Patients Be Anticoagulated After Intracerebral Hemorrhage?: A Decision Analysis, Stroke, vol.34, issue.7, 2003.
DOI : 10.1161/01.STR.0000078311.18928.16

URL : http://stroke.ahajournals.org/content/strokeaha/34/7/1710.full.pdf

V. Siguret, A. Nguyen, M. Harboun, A. Chevallier, and S. Berigaud, Diffusion d'une fiche d'aide à la prescription pour l'initiation d'un traitement par warfarine dans un hôpital gériatrique : intérêt et difficultés de mise en place, Annales de Biologie Clinique, vol.64, issue.3, pp.245-51, 2006.

C. Gozalo, G. Pernod, and P. Sié, Épidémiologie et facteurs de risque hémorragique des traitements par les antivitamines K. Sang Thrombose Vaisseaux, pp.23-47, 2008.

E. Pautas, I. Gouin-thibault, M. Bebray, P. Gaussem, and V. Siguret, Haemorrhagic Complications of Vitamin K Antagonists in the Elderly, Drugs & Aging, vol.35, issue.10, pp.13-25, 2006.
DOI : 10.7326/0003-4819-137-4-200208200-00009

A. Guideline, The use of oral anticoagulants (warfarin) in older people, J Am Geriatr Soc, vol.50, pp.1439-1484, 2002.

L. Visser, F. Penning-van-beest, A. Kasbergen, A. Hofman, and B. Stricker, Overanticoagulation associated with combined use of antibacterial drugs and acenocoumarol or phenprocoumon anticoagulants, Thromb Haemost, vol.88, pp.705-715, 2002.

B. Vigué, B. Tremey, and K. Tazarourte, H??morragies sous antivitamines K : les freins ?? la prescription du PPSB, mythes et r??alit??s, Journal Europ??en des Urgences, vol.20, pp.1-9, 2007.
DOI : 10.1016/S0993-9857(07)80002-1

T. Hémostase, Cahier de formation Biologie médicale, 2000.